Executive Committee

An Executive Committee whose members represent the Forum's constituency groups directs the Forum's work. The Forum's Executive Committee determines what issues are appropriate for a review by the Forum and the scope of that review. The Executive Committee members assist in project planning and in identifying experts from their constituencies to attend Forum workshops, conferences and meetings.

Members of the Executive Committee may log-in to the members area by following this link: EC Members Login

Members of the Executive Committee are:

EC Member	Title	Affiliation
Judith Aberg, M.D. (Co-Chair)	Director of HIV	NYU School of Medicine
Jim Rooney, M.D. (Co-Chair)	Vice President of Clinical Research	Gilead Sciences
Cornelius Baker	National Policy Advisor	National Black Gay Men's Advocacy Coalition
Arlene Bardeguez, M.D., M.P.H., F.A.C.O.G.	Professor of OB/GYN and Director of HIV Services	Department of Obstetrics, Genecology & Women’s Health - New Jersey Medical School
Barry Bernstein, M.D.	Global Project Head of the Antiviral Global Project Team	Abbott Laboratories
Rob Camp	Community Constituency Group Representative	AIDS Clinical Trials Group (ACTG)
Vicki Cargill-Swiren, M.D.	Director of Minority Research & Clinical Studies	NIH Office of AIDS Research
Laura Cheever, M.D., Sc.M.	Deputy Associate Administrator (Acting)	HRSA
Ben Cheng, M.Sc.	Deputy Director	Forum for Collaborative HIV Research
Calvin Cohen, M.D.	Research Director	Harvard Vanguard Medical Associates/CRI New England
Deborah Cotton, M.D., M.P.H.	Professor of Medicine	Boston Medical Center
Paul Dalton	Treatment Advocacy Associate	Project Inform
Carl Dieffenbach, Ph.D.	Acting Director	DAIDS/NIAID/NIH
Victor DeGruttola, Sc.D.	Senior Statistician	Harvard School of Public Health
Shalini Eddens, M.P.H.	Training and Education Director	WORLD
Ayman El-Mohandes, M.B.B.Ch, MD, MPH	Professor and Interim Chair, Department of Prevention and Community Health	George Washington University
Jean-Louis Faudon	Director	Eurofins - Viralliance
Sheldon Fields, Ph.D., RN, APRN, BC, FNP, AACRN, FNAP, FAANP	Assistant Professor of Nursing	Representative for ANAC (Association for Nurses in AIDS Care)
Wayne Greaves, M.D.	Clinical Project Director	Schering Plough Research Institute
Michael Greenberg, Ph.D.	Vice President, Research	Trimeris
Roy Gulick, M.D., M.P.H.	Director, Associate Professor of Medicine	Cornell Medical Center
David Haerry	Chair - European Community Advisory Board	EATG
George Hanna, M.D.	Executive Director, Virology	Bristol-Myers Squibb
Lucy Hattingh	Director of International Marketing, Virology - HIV	Roche Molecular Systems, Inc.
King Holmes, M.D., Ph.D.	Chief, Infectious Diseases	University of Washington, Harborview Medical Center
Michael Horberg, M.D., F.A.C.P.	Director/Chair	HIV/AIDS Policy, Quality Improvement, and Research/KPNC Central Research Committee
Robin Isaacs, M.D.	Executive Director, Infectious Diseases and HIV Vaccine Clinical Research	Merck & Co., Inc
Daniel Kuritzkes, M.D.	Director of AIDS Research	Brigham & Women’s Hospital
Michael Lederman, M.D.	Scott R. Inkley Professor of Medicine	Case Western Reserve University/University Hospital
Franck Lemiale, Pharm.D., Ph.D.	Immunology Director	VIRxSYS
Richard Levy, M.D.	Senior Vice President, Drug Development	Incyte Corporation
Christine Lubinski	Executive Director	HIV Medicine Association
Kimberly Manhard	Senior Vice President, Regulatory Affairs and Operations	Ardea Biosciences
Karen Manson	Vice President of Communications	Tibotec BVBA
Doug Mayers, M.D.	Executive Vice President and Chief Medical Officer	Idenix Pharmaceuticals
Scott McCallister, M.D.	Chief Medical Officer	Panacos
Craig McClure	Executive Director	International AIDS Society
Veronica Miller, Ph.D.	Executive Director	Forum for Collaborative HIV Research
Nathalie Morgensztejn	Head - Clinical Assessment of Anti-Infectives/Anti-HIV Drugs	Agence Francaise de Securite Sanitaire des Produits de Sante (EMEA)
Jacques Normand, Ph.D.	Director of HIV/AIDS Research	NIDA/NIH
Sandra Palleja, M.D.	Executive Vice President and Chief Medical Officer	Tobira Therapeutics
Chris Petropolous, Ph.D.	Vice President of Research and Development, Virology and Chief Scientific Officer	Monogram Biosciences
Dwight Peavy	Executive Director	Newark EMA HIV Health Services Planning Council
Peter Piliero, M.D.	Director, Clinical and Scientific Affairs Virology	Boehringer Ingelheim
John Pottage, M.D.	Vice President, Antivirals Global Clinical Development Infectious Diseases	GlaxoSmithKline
Renee Ridzon, M.D.	Senior Program Officer for HIV/AIDS and TB	Bill & Melinda Gates Foundation
Monica Ruiz, Ph.D., MPH	Deputy Director	Acting Representative for American Foundation for AIDS Research (amfAR)
Caroline Ryan, M.D., M.P.H.	Chief Technical Officer	Office of the Global AIDS Coordinator
David Stanton, M.N., M.P.H.	Chief of the Division of Technical Leadership	USAID
Ellen Stover, Ph.D.	Director DMDBA	Office of AIDS/NIMH/NIH
Kimberly Struble, Pharm.D.	Team Leader	FDA
James Thommes, M.D.	Medical Director	Roche Laboratories
Randy Tressler, M.D.	Medical Director/HIV Medical Team Leader	Pfizer Global Pharmaceuticals
Ronald Valdisseri, M.D., M.P.H.	Chief Consultant	Department of Veterans Affairs
Linda Valleroy, Ph.D.	Epidemiologist	CDC
Ian Weller, M.D.	Professor	Royal Free & University College Medical School
Gloria Young	Vice President of Global HIV/AIDS Initiatives	BD Biosciences
TBD		Bayer HealthCare

Summary of the Executive Committee Retreat Report - March 18-19, 2003

Forum for Collaborative HIV Research
Department of Prevention and Community Health
School of Public Health and Health Services

2175 K St NW Ste 700
Washington, DC 20037
Phone: 202 530-2370
Fax: 202 530-3923
info@hivforum.org